{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:17:20Z","timestamp":1794590240601,"version":"4.9.1"},"reference-count":47,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"unspecified","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015250","name":"NIHR Bristol Biomedical Research Centre","doi-asserted-by":"publisher","award":["ACF-2015-25-002"],"award-info":[{"award-number":["ACF-2015-25-002"]}],"id":[{"id":"10.13039\/100015250","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015250","name":"NIHR Bristol Biomedical Research Centre","doi-asserted-by":"publisher","award":["DRF-2018-11-ST2-065"],"award-info":[{"award-number":["DRF-2018-11-ST2-065"]}],"id":[{"id":"10.13039\/100015250","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2023,4,21]]},"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                      epidemiology is changing in response to vaccination and some data suggest that empyema incidence is increasing. However, differences exist between the UK and US studies. We describe trends in the clinical phenotype of adult pneumococcal pleural infection, including simple parapneumonic effusions (SPE) in the pneumococcal conjugate vaccination (PCV) era.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine whether there were differences in pneumococcal disease presentation and severity associated with pleural infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study, all adults \u226516 years admitted to three large UK hospitals, 2006\u20132018 with pneumococcal disease. 2477 invasive pneumococcal cases were identified: 459 SPE and 100 pleural infection cases. Medical records were reviewed for each clinical episode. Serotype data were obtained from the UK Health Security Agency national reference laboratory.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Incidence increased over time, including non-PCV-serotype disease. PCV7-serotype disease declined following paediatric PCV7 introduction, but the effect of PCV13 was less apparent as disease caused by the additional six serotypes plateaued with serotypes 1 and 3 causing such parapneumonic effusions from 2011 onwards.<\/jats:p>\n                    <jats:p>Patients with pleural infection had a median survival 468 days (95% CI 340 to 590) vs 286 days (95% CI 274 to 335) in those with SPE. Pleural infection associated with frank pus had lower 90-day mortality than pleural infection without pus (0% vs 29%, p&lt;0.0001). 90-day mortality could be predicted by baseline increased RAPID (Renal, Age, Purulence, Infection source, and Dietary factors) score (HR 15.01, 95% CI 1.24 to 40.06, p=0.049).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pneumococcal infection continues to cause severe disease despite the introduction of PCVs. The predominance of serotype 1 and 3 in this adult UK cohort is in keeping with previous studies in paediatric and non-UK studies. Rising non-PCV serotype disease and limited impact of PCV13 on cases caused by serotypes 1 and 3 offset the reductions in adult pneumococcal parapneumonic effusion disease burden observed following the introduction of the childhood PCV7 programme.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2022-001440","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T10:11:39Z","timestamp":1683281499000},"page":"e001440","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Parapneumonic effusions related to\n                    <i>Streptococcus pneumoniae<\/i>\n                    : serotype and disease severity trends from 2006 to 2018 in Bristol, UK"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3923-1773","authenticated-orcid":false,"given":"Catherine","family":"Hyams","sequence":"first","affiliation":[{"name":"Academic Respiratory Unit, University of Bristol, Bristol, UK"},{"name":"Bristol Vaccine Centre, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T","family":"Arnold","sequence":"additional","affiliation":[{"name":"Academic Respiratory Unit, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Heath","sequence":"additional","affiliation":[{"name":"Vaccine and Testing Research Team, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahin","family":"Amin-Chowdhury","sequence":"additional","affiliation":[{"name":"National Infection Service, UKHSA, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hettle","sequence":"additional","affiliation":[{"name":"Microbiology Department, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK"},{"name":"Microbiology Department, North Bristol NHS Trust, Westbury on Trym, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Ruffino","sequence":"additional","affiliation":[{"name":"Acute Medical Unit, Southmead Hospital, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"North","sequence":"additional","affiliation":[{"name":"Microbiology Department, North Bristol NHS Trust, Westbury on Trym, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charli","family":"Grimes","sequence":"additional","affiliation":[{"name":"Academic Respiratory Unit, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman K","family":"Fry","sequence":"additional","affiliation":[{"name":"National Infection Service, UKHSA, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Williams","sequence":"additional","affiliation":[{"name":"Microbiology Department, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Challen","sequence":"additional","affiliation":[{"name":"Engineering Mathematics, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Danon","sequence":"additional","affiliation":[{"name":"Engineering Mathematics, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O Martin","family":"Williams","sequence":"additional","affiliation":[{"name":"Microbiology Department, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamez","family":"Ladhani","sequence":"additional","affiliation":[{"name":"National Infection Service, UKHSA, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Finn","sequence":"additional","affiliation":[{"name":"Bristol Vaccine Centre, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Maskell","sequence":"additional","affiliation":[{"name":"Academic Respiratory Unit, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"2025083112230064000_10.1.e001440.1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.3.800"},{"key":"2025083112230064000_10.1.e001440.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03692.x"},{"key":"2025083112230064000_10.1.e001440.3","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.105080"},{"key":"2025083112230064000_10.1.e001440.4","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00000211"},{"key":"2025083112230064000_10.1.e001440.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022823"},{"key":"2025083112230064000_10.1.e001440.6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu524"},{"key":"2025083112230064000_10.1.e001440.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2018.07.004"},{"key":"2025083112230064000_10.1.e001440.8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/jamainternmed.2016.8289","article-title":"Developing better pneumococcal vaccines for adults","volume":"177","author":"Weinberger","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2025083112230064000_10.1.e001440.9","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.vaccine.2015.12.066","article-title":"Invasive pneumococcal disease: clinical outcomes and patient characteristics 2\u20136 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands","volume":"34","author":"Wagenvoort","year":"2016","journal-title":"Vaccine"},{"key":"2025083112230064000_10.1.e001440.10","unstructured":"UKHSA . Pneumococcal: the Green book. 2020: 1\u201313."},{"key":"2025083112230064000_10.1.e001440.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30052-5"},{"key":"2025083112230064000_10.1.e001440.12","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70090-1"},{"key":"2025083112230064000_10.1.e001440.13","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)70044-7"},{"key":"2025083112230064000_10.1.e001440.14","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-213725"},{"key":"2025083112230064000_10.1.e001440.15","unstructured":"Shebl E . Parapneumonic pleural effusions and empyema thoracis. In: StatPearls [Internet]. StatPearls Publishing, 2022."},{"key":"2025083112230064000_10.1.e001440.16","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1080\/22221751.2021.1945955","article-title":"Streptococcus pneumoniae septic arthritis in adults in Bristol and Bath, United Kingdom, 2006-2018: a 13-year retrospective observational cohort study","volume":"10","author":"Hyams","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"2025083112230064000_10.1.e001440.17","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1093\/cid\/ciaa043","article-title":"Characteristics of invasive pneumococcal disease caused by emerging serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine in England: a prospective observational cohort study, 2014-2018","volume":"71","author":"Amin-Chowdhury","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025083112230064000_10.1.e001440.18","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(80)90460-X"},{"key":"2025083112230064000_10.1.e001440.19","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.5.377"},{"key":"2025083112230064000_10.1.e001440.20","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-1558"},{"key":"2025083112230064000_10.1.e001440.21","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00130-2020","article-title":"Prospective validation of the rapid clinical risk prediction score in adult patients with pleural infection: the pilot study","volume":"56","author":"Corcoran","year":"2020","journal-title":"Eur Respir J"},{"key":"2025083112230064000_10.1.e001440.22","doi-asserted-by":"publisher","DOI":"10.3201\/eid2301.160897"},{"key":"2025083112230064000_10.1.e001440.23","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30419-0"},{"key":"2025083112230064000_10.1.e001440.24","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/975312"},{"key":"2025083112230064000_10.1.e001440.25","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.chest.2021.05.026","article-title":"Epidemiology of adult pleural disease in the United States","volume":"160","author":"Mummadi","year":"2021","journal-title":"Chest"},{"key":"2025083112230064000_10.1.e001440.26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1378\/chest.13-1912","article-title":"Incidence, length of stay, and prognosis of hospitalized patients with pleural empyema: a 15-year Danish nationwide cohort study","volume":"145","author":"S\u00f8gaard","year":"2014","journal-title":"Chest"},{"key":"2025083112230064000_10.1.e001440.27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03546-2020","article-title":"Epidemiology of pleural empyema in English hospitals and the impact of influenza","volume":"57","author":"Arnold","year":"2021","journal-title":"Eur Respir J"},{"key":"2025083112230064000_10.1.e001440.28","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-014-2062-6"},{"key":"2025083112230064000_10.1.e001440.29","doi-asserted-by":"publisher","DOI":"10.1086\/374624"},{"key":"2025083112230064000_10.1.e001440.30","doi-asserted-by":"publisher","DOI":"10.1086\/655828"},{"key":"2025083112230064000_10.1.e001440.31","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01056-09"},{"key":"2025083112230064000_10.1.e001440.32","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijbiomac.2019.12.022","article-title":"In vitro and in vivo characterization of the interaction, proinflammatory, immunomodulatory and antigenic properties of capsular polysaccharide from Streptococcus pneumoniae serotype 1","volume":"143","author":"Kaushal","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"2025083112230064000_10.1.e001440.33","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-021-06430-y","article-title":"Invasive pneumococcal disease in persons with predisposing factors is dominated by non-vaccine serotypes in Southwest Sweden","volume":"21","author":"Bergman","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2025083112230064000_10.1.e001440.34","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.613287","article-title":"Sugar-Coated killer: serotype 3 pneumococcal disease","volume":"10","author":"Luck","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"2025083112230064000_10.1.e001440.35","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir749"},{"key":"2025083112230064000_10.1.e001440.36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007438","article-title":"Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci","volume":"14","author":"Azarian","year":"2018","journal-title":"PLOS Pathog"},{"key":"2025083112230064000_10.1.e001440.37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003868","article-title":"Dominant role of nucleotide substitution in the diversification of serotype 3 pneumococci over decades and during a single infection","volume":"9","author":"Croucher","year":"2013","journal-title":"PLOS Genet"},{"key":"2025083112230064000_10.1.e001440.38","doi-asserted-by":"crossref","DOI":"10.3390\/genes10110845","article-title":"Evolution of Streptococcus pneumoniae serotype 3 in England and Wales: a major vaccine evader","volume":"10","author":"Groves","year":"2019","journal-title":"Genes (Basel)"},{"key":"2025083112230064000_10.1.e001440.39","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00541-2019","article-title":"A systematic review of comorbidities and outcomes of adult patients with pleural infection","volume":"54","author":"Cargill","year":"2019","journal-title":"Eur Respir J"},{"key":"2025083112230064000_10.1.e001440.40","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1513\/AnnalsATS.201601-082OC","article-title":"Unilateral pleural effusions with more than one apparent etiology. A prospective observational study","volume":"13","author":"Bintcliffe","year":"2016","journal-title":"Annals ATS"},{"key":"2025083112230064000_10.1.e001440.41","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1996.00440180068008"},{"key":"2025083112230064000_10.1.e001440.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2015.02.003"},{"key":"2025083112230064000_10.1.e001440.43","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.21037\/jtd-21-1083","article-title":"Outcome of parapneumonic empyema managed surgically or by fibrinolysis: a multicenter study","volume":"13","author":"Federici","year":"2021","journal-title":"J Thorac Dis"},{"key":"2025083112230064000_10.1.e001440.44","doi-asserted-by":"publisher","DOI":"10.1378\/chest.111.6.1548"},{"key":"2025083112230064000_10.1.e001440.45","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1513\/AnnalsATS.201505-272OC","article-title":"Predicting long-term outcomes in pleural infections. rapid score for risk stratification","volume":"12","author":"White","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"2025083112230064000_10.1.e001440.46","unstructured":"Maguire D , Dunn P , McKenna H . How hospital activity in the NHS in England has changed over time. 2016."},{"key":"2025083112230064000_10.1.e001440.47","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00223-2019","article-title":"Urinary antigen testing for pneumococcal pneumonia: is there evidence to make its use uncommon in clinical practice?","volume":"6","author":"Hyams","year":"2020","journal-title":"ERJ Open Res"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2022-001440","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T19:23:10Z","timestamp":1756668190000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2022-001440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,5,5]]},"published-print":{"date-parts":[[2023,5]]}},"alternative-id":["10.1136\/bmjresp-2022-001440"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2022-001440","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.03.16.22272461","asserted-by":"object"}]},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5]]}}}